Haemonetics Corp. Downgraded by Benchmark Co. to Hold (HAE)

Haemonetics Corp. Downgraded by Benchmark Co. to Hold (HAE)

35 earnings per share for the current fiscal year. Haemonetics Corporation is a healthcare company. The Company is engaged developing and manufacturing automated blood component collection devices and…

6
Like
Save

Comments

Write a comment

*